GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.

Have any questions? Please email us at ecoliwiki@gmail.com

PMID:9260945

From GONUTS
Jump to: navigation, search
Citation

Cáceres, NE, Harris, NB, Wellehan, JF, Feng, Z, Kapur, V and Barletta, RG (1997) Overexpression of the D-alanine racemase gene confers resistance to D-cycloserine in Mycobacterium smegmatis. J. Bacteriol. 179:5046-55

Abstract

D-Cycloserine is an effective second-line drug against Mycobacterium avium and Mycobacterium tuberculosis. To analyze the genetic determinants of D-cycloserine resistance in mycobacteria, a library of a resistant Mycobacterium smegmatis mutant was constructed. A resistant clone harboring a recombinant plasmid with a 3.1-kb insert that contained the glutamate decarboxylase (gadA) and D-alanine racemase (alrA) genes was identified. Subcloning experiments demonstrated that alrA was necessary and sufficient to confer a D-cycloserine resistance phenotype. The D-alanine racemase activities of wild-type and recombinant M. smegmatis strains were inhibited by D-cycloserine in a concentration-dependent manner. The D-cycloserine resistance phenotype in the recombinant clone was due to the overexpression of the wild-type alrA gene in a multicopy vector. Analysis of a spontaneous resistant mutant also demonstrated overproduction of wild-type AlrA enzyme. Nucleotide sequence analysis of the overproducing mutant revealed a single transversion (G-->T) at the alrA promoter, which resulted in elevated beta-galactosidase reporter gene expression. Furthermore, transformants of Mycobacterium intracellulare and Mycobacterium bovis BCG carrying the M. smegmatis wild-type alrA gene in a multicopy vector were resistant to D-cycloserine, suggesting that AlrA overproduction is a potential mechanism of D-cycloserine resistance in clinical isolates of M. tuberculosis and other pathogenic mycobacteria. In conclusion, these results show that one of the mechanisms of D-cycloserine resistance in M. smegmatis involves the overexpression of the alrA gene due to a promoter-up mutation.

Links

PubMed PMC179361

Keywords

Alanine Racemase/biosynthesis; Alanine Racemase/genetics; Alanine Racemase/metabolism; Amino Acid Sequence; Antibiotics, Antitubercular/pharmacology; Cloning, Molecular; Cycloserine/pharmacology; Drug Resistance, Microbial/genetics; Gene Expression Regulation, Bacterial; Genomic Library; Molecular Sequence Data; Mutation; Mycobacterium/drug effects; Mycobacterium/enzymology; Mycobacterium/genetics; Mycobacterium avium Complex/genetics; Mycobacterium bovis/genetics; Open Reading Frames; Promoter Regions, Genetic; Sequence Alignment

Significance

Annotations

Gene product Qualifier GO Term Evidence Code with/from Aspect Extension Notes Status

MYCSM:ALR

GO:0008784: alanine racemase activity

ECO:0000314:

F

Figure 5: Depicts alanine racemase activity among different strains. Strain GPM14 shows marked overproduction of d-alanine racemase as a result of a single base change from T -> G in the alrA gene promoter as described in the "Results" section.

complete
CACAO 4949


See also

References

See Help:References for how to manage references in GONUTS.